BAMBI

BAMBI

Target · Pseudoreceptor

BAMBI BMP and activin membrane bound inhibitor · NMA

BAMBI (BMP and activin membrane bound inhibitor, also known as NMA) is a transmembrane glycoprotein that negatively regulates TGF-beta signalling. It resembles type I TGF-beta family receptors but acts as a pseudoreceptor, and it belongs to the BAMBI family. Browse Assay Genie's current range of BAMBI research reagents below, or read on for the biology behind the target.

Membrane proteinTGF-beta pseudoreceptorLacks kinase domain
260 aa
Protein length
~29 kDa
Molecular weight
10p12.1
Gene locus
BAMBI family
Protein family
Target information

What is BAMBI (BMP and activin membrane bound inhibitor)?

BAMBI is a negative regulator of TGF-beta signalling. The protein is related to the type I receptors of the transforming growth factor-beta (TGF-beta) family, whose members have important roles in signal transduction across many developmental and pathological processes. Unlike those receptors, however, BAMBI is a pseudoreceptor: it lacks the intracellular serine/threonine kinase domain that signalling requires. Because it resembles a receptor but cannot transmit a signal, it is thought to dampen pathway activity rather than drive it.

The BAMBI gene encodes a transmembrane glycoprotein and the protein is found at the membrane. It is the founding member of the BAMBI family. In humans the gene is also referred to by the alias NMA, and its full name reflects the way it was first characterised through its Xenopus laevis homologue, which is why earlier HGNC records list it as BMP and activin membrane-bound inhibitor homolog (Xenopus laevis). Mouse and rat each have an ortholog named Bambi.

Similar proteins in frog, mouse and zebrafish function as negative regulators of TGF-beta. This has led to the suggestion that the encoded protein may limit the signalling range of the TGF-beta family during early embryogenesis. For researchers, the BAMBI protein is therefore a useful point of study for how TGF-beta family signalling is restrained in development and in disease-related processes in which the pathway is involved.

TGF-beta signalling research

BAMBI negatively regulates TGF-beta signalling, making it a key subject for studying how this pathway is restrained.

Developmental biology

BAMBI may limit the signalling range of the TGF-beta family during early embryogenesis, which makes it relevant to developmental studies.

Pseudoreceptor mechanisms

Lacking an intracellular kinase domain, BAMBI is a model for how receptor-like proteins can inhibit signalling without transmitting it.

Comparative signalling studies

Related proteins in frog, mouse and zebrafish act as negative regulators of TGF-beta, supporting cross-species comparison.

Background

BAMBI frequently asked questions

What does BAMBI do?

BAMBI negatively regulates TGF-beta signalling. It is a transmembrane pseudoreceptor related to type I TGF-beta family receptors but lacking the intracellular serine/threonine kinase domain needed for signalling. It may limit the signalling range of the TGF-beta family during early embryogenesis.

What other names does BAMBI go by?

The HGNC full name is BMP and activin membrane bound inhibitor, and NMA is a listed alias. UniProt names the protein BMP and activin membrane-bound inhibitor homolog. An earlier HGNC name referenced the Xenopus laevis homologue.

Is BAMBI conserved across species?

Yes. Mouse and rat have orthologs named Bambi, and similar proteins in frog and zebrafish function as negative regulators of TGF-beta. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other TGF-beta family members, receptors and pathway regulators with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13145; product specifications from Assay Genie datasheets.

BAMBI Product listing